DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare services and solutions to federal agencies, today announced financial results for its fiscal second quarter ended March 31, 2022.

Highlights

  • Second quarter revenue increased to $108.7 million in fiscal 2022 from $61.5 million in fiscal 2021, reflecting the previously-announced award of two FEMA contracts to support Alaska, which accounted for approximately $39.8 million of revenue
  • Excluding these short-term contracts, second quarter revenue rose to $68.9 million in fiscal 2022, an increase of 12% over the prior-year period
  • Earnings were $7.2 million, or $0.50 per diluted share, for the fiscal 2022 second quarter versus $2.6 million, or $0.19 per diluted share, for the second quarter of fiscal 2021
  • Excluding contributions from the aforementioned short-term FEMA contracts, earnings on a non-GAAP basis for the fiscal 2022 second quarter were $3.1 million, or $0.22 per diluted share
  • The Company's term loan was reduced to $37.5 million from $42.9 million during the second quarter;
  • Contract backlog was $554.7 million as of March 31, 2022 versus $633.6 million at the end of the first quarter, with approximately $30.0 million of the latter related to Alaska-based task orders

Management Discussion“Our second quarter continued the positive trends of the first, with strong organic revenue growth and contributions from our Alaska contracts resulting in solid financial performance,” said DLH President and Chief Executive Officer Zach Parker. “The overall business, net of short-term FEMA work, expanded 12% year-over-year, reflecting increased demand for services even during a slower-than-anticipated award environment. In addition, we achieved an operating margin of 9.4% and continued our early repayment of acquisition debt.

“With passage of the fiscal 2022 omnibus appropriations bill in March, contract decision-making should accelerate – at the same time DLH is expected to benefit from obtaining FedRamp authorization for its Infinibyte® data analytics solutions. We are pleased with the progress we are making to strengthen and diversify our capabilities across the key federal markets we serve. While focused on paying down debt and improving the balance sheet, we continue to actively look at potential acquisitions that may enhance and broaden our portfolio of technology-enabled applications. It’s an exciting time at DLH, with many opportunities ahead of us – leveraging our leadership position in innovative, healthcare-related services and solutions to build a unique, customer-centric enterprise that, at the same time, creates value for our shareholders.”

Results for the Three Months Ended March 31, 2022Revenue for the second quarter of fiscal 2022 was $108.7 million versus $61.5 million in the prior-year period. The increase was primarily due to the Company’s work for FEMA in Alaska – which added approximately $39.8 million in revenue – along with other new business wins and generally higher volume across a number of legacy programs.

Income from operations was $10.3 million for the quarter versus $4.6 million in the prior-year period and, as a percent of revenue, the Company reported an operating margin of 9.4% in fiscal 2022 versus 7.5% in fiscal 2021. Income from operations increased primarily due to performance on the FEMA task orders. Income from operations on the remaining contract portfolio was essentially flat, notwithstanding the increase in revenue, reflecting planned investment in human capital management and business development as we continue to build and strengthen our sustaining business.    

Interest expense was $0.6 million in the fiscal second quarter of 2022 versus $1.0 million in the prior-year period, reflecting lower debt outstanding. Income before taxes was $9.7 million this year versus $3.6 million in fiscal 2021, representing 8.9% and 5.9% of revenue, respectively, for each period.

For the three months ended March 31, 2022 and 2021, respectively, DLH recorded a $2.5 million and $1.0 million provision for tax expense. The Company reported net income of approximately $7.2 million, or $0.50 per diluted share, for the second quarter of fiscal 2022 versus $2.6 million, or $0.19 per diluted share, for the second quarter of fiscal 2021. As a percent of revenue, net income was 6.6% for the second quarter of fiscal 2022 versus 4.2% for the prior-year period.

On a non-GAAP basis, EBITDA for the three months ended March 31, 2022 was approximately $12.1 million versus $6.6 million in the prior-year period, or 11.2% and 10.8% of revenue, respectively. A reconciliation of the Company's performance for the quarter less the contribution of the FEMA task orders compared to the prior-year period is included at the back of this document.

Key Financial IndicatorsFiscal year to date, DLH used $14.8 million in operating cash, reflecting performance of the $22.2 million deferred revenue on the aforementioned FEMA contracts, for which there were advance payments in the fourth quarter of fiscal 2021. Excluding the impact of the FEMA contracts, DLH would have generated positive operating cash flow fiscal year to date.  

Fiscal year to date, accounts receivable increased by $28.7 million, including $13.6 million related to the FEMA contracts, for which the cash flow impact was largely offset by corresponding subcontractor accruals. Both the receivables and corresponding payables on the FEMA contracts were largely settled subsequent to quarter end. The remaining increase in accounts receivable is related to normal fluctuations in the timing of customer payments and to growth in the overall business volume.

As of March 31, 2022, the Company had cash of $0.4 million and debt outstanding under its credit facility of $37.5 million, versus cash of $24.1 million and debt outstanding of $46.8 million as of September 30, 2021. The Company has satisfied mandatory principal amortization on the loan facility until December 31, 2024. Subsequent to the end of the quarter, the Company made additional debt payments, reducing the outstanding balance on the term loan to $33 million. As a result of these payments, DLH retired the $70 million debt associated with the Social & Scientific Systems, Inc. acquisition more than two years early. The Company intends to continue using cash to make debt prepayments when possible.

At March 31, 2022, total backlog was approximately $554.7 million, including funded backlog of approximately $82.4 million and unfunded backlog of $472.3 million.

Conference Call and Webcast DetailsDLH management will discuss second quarter results and provide a general business update, including current competitive conditions and strategies, during a conference call beginning at 11:00 AM Eastern Time tomorrow, May 5, 2022. Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256.   Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call.     

A digital recording of the conference call will be available for replay two hours after the completion of the call and can be accessed on the DLH Investor Relations website or by dialing 877-344-7529 and entering the conference ID 7532524.

About DLHDLH (NASDAQ:DLHC) delivers improved health and readiness solutions for federal programs through research, development, and innovative care processes. The Company’s experts in public health, performance evaluation, and health operations solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 2,300 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to public health to improve the lives of millions. For more information, visit www.DLHcorp.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding estimates of future revenues, operating income, earnings and cash flow. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements made in this release due to a variety of factors, including: the outbreak of the novel coronavirus (“COVID-19”), including the measures to reduce its spread, and its impact on the economy and demand for our services, are uncertain, cannot be predicted, and may precipitate or exacerbate other risks and uncertainties; the risk that we will not realize the anticipated benefits of   acquisitions; the challenges of managing larger and more widespread operations; contract awards in connection with re-competes for present business and/or competition for new business; compliance with new bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the ability to successfully integrate the operations of acquisitions; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2021, as well as subsequent reports filed thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business.

Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements, except as may be required by law.

CONTACTS:

INVESTOR RELATIONS
Contact: Chris Witty
Phone: 646-438-9385
Email: cwitty@darrowir.com

TABLES TO FOLLOW

DLH HOLDINGS CORP.CONSOLIDATED STATEMENTS OF INCOME(Amounts in thousands except per share amounts)

    (unaudited)   (unaudited)
    Three Months Ended   Six Months Ended
    March 31,   March 31,
      2022     2021     2022     2021
Revenue   $ 108,699   $ 61,506   $ 261,500   $ 119,358
Cost of Operations:                
Contract costs     88,831     48,722     221,517     94,727
General and administrative costs     7,733     6,135     14,644     12,285
Depreciation and amortization     1,881     2,029     3,866     4,091
Total operating costs     98,445     56,886     240,027     111,103
Income from operations     10,254     4,620     21,473     8,255
Interest expense, net     554     1,004     1,226     2,084
Income before income taxes     9,700     3,616     20,247     6,171
Income tax expense     2,522     1,049     5,265     1,790
Net income   $ 7,178   $ 2,567   $ 14,982   $ 4,381
                 
Net income per share - basic   $ 0.56   $ 0.20   $ 1.17   $ 0.35
Net income per share - diluted   $ 0.50   $ 0.19   $ 1.04   $ 0.32
Weighted average common shares outstanding                
Basic     12,778     12,544     12,763     12,521
Diluted     14,442     13,570     14,368     13,568
                         

DLH HOLDINGS CORP.CONSOLIDATED BALANCE SHEETS(Amounts in thousands except par value of shares)

    March 31,2022   September 30,2021
    (unaudited)    
ASSETS        
Current assets:        
Cash   $ 359     $ 24,051  
Accounts receivable     62,152       33,447  
Other current assets     3,599       4,265  
Total current assets     66,110       61,763  
Equipment and improvements, net     1,427       1,912  
Operating lease right-of-use assets     17,999       19,919  
Goodwill     65,643       65,643  
Intangible assets, net     44,177       47,469  
Other long-term assets     398       464  
Total assets   $ 195,754     $ 197,170  
LIABILITIES AND SHAREHOLDERS’ EQUITY        
Current liabilities:        
Operating lease liabilities - current   $ 2,216     $ 2,261  
Accrued payroll     12,464       9,125  
Deferred revenue           22,273  
Accounts payable, accrued expenses, and other current liabilities     44,317       32,717  
Total current liabilities     58,997       66,376  
Long-term liabilities:        
Deferred taxes, net     1,176       1,176  
Operating lease liabilities - long-term     17,582       19,374  
Debt obligations - long-term, net of deferred financing costs     35,638       44,636  
Total long-term liabilities     54,396       65,186  
Total liabilities     113,393       131,562  
Shareholders' equity:        
Common stock, $0.001 par value; authorized 40,000 shares; issued and outstanding 12,794 and 12,714 at March 31, 2022 and September 30, 2021, respectively     13       13  
Additional paid-in capital     89,664       87,893  
Accumulated deficit     (7,316 )     (22,298 )
Total shareholders’ equity     82,361       65,608  
Total liabilities and shareholders' equity   $ 195,754     $ 197,170  
                 

DLH HOLDINGS CORP. CONSOLIDATED STATEMENTS OF CASH FLOWS(Amounts in thousands)

    (unaudited)
    Six Months Ended
    March 31,
      2022       2021  
Operating activities        
Net income   $ 14,982     $ 4,381  
Adjustments to reconcile net income to net cash provided by (used in) operating activities:        
Depreciation and amortization     3,866       4,091  
Amortization of deferred financing costs charged to interest expense     319       413  
Stock based compensation expense     1,309       844  
Deferred taxes, net           1,512  
Changes in operating assets and liabilities        
Accounts receivable     (28,705 )     (9,134 )
Other current assets     666       30  
Accrued payroll     3,339       1,401  
Deferred revenue     (22,273 )      
Accounts payable, accrued expenses, and other current liabilities     11,600       2,245  
Other long-term assets and liabilities     82       336  
Net cash provided by (used in) operating activities     (14,815 )     6,119  
Investing activities        
Business acquisition adjustment, net of cash acquired           59  
Purchase of equipment and improvements     (89 )     (53 )
Net cash provided by (used in) investing activities     (89 )     6  
Financing activities        
Proceeds from debt obligations     13,500       18,950  
Repayment of debt obligations     (22,750 )     (26,200 )
Payment of deferred financing costs           (43 )
Proceeds from issuance of common stock upon exercise of options and warrants     462       231  
Net cash used in financing activities     (8,788 )     (7,062 )
         
Net change in cash     (23,692 )     (937 )
Cash at beginning of period     24,051       1,357  
Cash at end of period   $ 359     $ 420  
         
Supplemental disclosure of cash flow information        
Cash paid during the period for interest   $ 896     $ 1,639  
Cash paid during the period for income taxes   $ 3,482     $ 184  
                 

Revenue Metrics

    Six Months Ended
    March 31,   March 31,
    2022     2021  
Market Mix:        
Defense/VA   29 %   59 %
Human Services and Solutions   57 %   14 %
Public Health/Life Sciences   14 %   27 %
         
Contract Mix:        
Time and Materials   84 %   76 %
Cost Reimbursable   9 %   20 %
Firm Fixed Price   7 %   4 %
         
Prime vs Sub:        
Prime   94 %   89 %
Subcontractor   6 %   11 %
             

Non-GAAP Financial MeasuresThe Company uses EBITDA and EBITDA as a percent of revenue as supplemental non-GAAP measures of performance. We define EBITDA as net income excluding (i) interest expense, (ii) provision for or benefit from income taxes and (iii) depreciation and amortization. EBITDA as a percent of revenue is EBITDA for the measurement period divided by revenue for the same period.

The Company is presenting additional non-GAAP measures to describe the impact from two short-term FEMA task orders' on its financial performance for the three and six months periods ended March 31, 2022. The measures presented are revenue, operating income, net income, diluted earnings per share, and EBITDA for our enterprise contract portfolio less the respective performance on the FEMA task orders. These resulting measures present the remaining contract portfolio's quarterly financial performance compared to results delivered in the prior year period. Definitions of these additional non-GAAP measures are set forth in the footnotes to the reconciliation table below.

These non-GAAP measures of performance are used by management to conduct and evaluate its business during its review of operating results for the periods presented. Management and the Company's Board utilize these non-GAAP measures to make decisions about the use of the Company's resources, analyze performance between periods, develop internal projections and measure management performance. We believe that these non-GAAP measures are useful to investors in evaluating the Company's ongoing operating and financial results and understanding how such results compare with the Company's historical performance.

Reconciliation of GAAP net income to EBITDA, a non-GAAP measure:

    Three Months Ended   Six Months Ended
    March 31,   March 31,
(in thousands)     2022       2021     Change     2022       2021     Change
Net income   $ 7,178     $ 2,567     $ 4,611     $ 14,982     $ 4,381     $ 10,601  
(i) Interest expense, net     554       1,004       (450 )     1,226       2,084       (858 )
(ii) Provision for taxes     2,522       1,049       1,473       5,265       1,790       3,475  
(iii) Depreciation and amortization     1,881       2,029       (148 )     3,866       4,091       (225 )
EBITDA   $ 12,135     $ 6,649     $ 5,486     $ 25,339     $ 12,346     $ 12,993  
                         
Net income as a % of revenue     6.6 %     4.2 %     2.4 %     5.7 %     3.7 %     2.0 %
EBITDA as a % of revenue     11.2 %     10.8 %     0.4 %     9.7 %     10.3 %   (0.6)%
Revenue   $ 108,699     $ 61,506     $ 47,193     $ 261,500     $ 119,358     $ 142,142  
                                                 

Reconciliation of GAAP revenue, operating income, net income, diluted earnings per share, and non-GAAP EBITDA reported for the three and six months ended to the same metrics for our contract portfolio less the FEMA task orders:

      Three Months Ended   Six Months Ended
      March 31,   March 31,
( in thousands) Ref     2022     2021   Change     2022     2021   Change
Revenue                          
Total enterprise     $ 108,699   $ 61,506   $ 47,193     $ 261,500   $ 119,358   $ 142,142
Less: FEMA task orders to support Alaska (a)     39,764         39,764       130,889         130,889
Remaining contract portfolio (a)   $ 68,935     61,506     7,429     $ 130,611   $ 119,358   $ 11,253
                           
Operating income                          
Total enterprise     $ 10,254   $ 4,620   $ 5,634     $ 21,473   $ 8,255   $ 13,218
Less: FEMA task orders to support Alaska (b)     5,525   $   $ 5,525       11,871         11,871
Remaining contract portfolio (b)   $ 4,729   $ 4,620   $ 109     $ 9,602   $ 8,255   $ 1,347
                           
Net income                          
Total enterprise     $ 7,178   $ 2,567   $ 4,611     $ 14,982   $ 4,381   $ 10,601
Less: FEMA task orders to support Alaska (c)     4,089         4,089       8,785         8,785
Remaining contract portfolio (c)   $ 3,089   $ 2,567   $ 522     $ 6,197   $ 4,381   $ 1,816
                           
Diluted earnings per share                          
Total enterprise     $ 0.50   $ 0.19   $ 0.31     $ 1.04   $ 0.32   $ 0.72
Less: FEMA task orders to support Alaska (d)     0.28         0.28       0.61         0.61
Remaining contract portfolio (d)   $ 0.22   $ 0.19   $ 0.03     $ 0.43   $ 0.32   $ 0.11
                           
EBITDA                          
Total enterprise     $ 12,135   $ 6,649   $ 5,486     $ 25,339   $ 12,346   $ 12,993
Less: FEMA task orders to support Alaska (e)     5,525         5,525       11,871         11,871
Remaining contract portfolio (e)   $ 6,610   $ 6,649   $ (39 )   $ 13,468   $ 12,346   $ 1,122

Ref (a): Revenue for the Company’s remaining contract portfolio less the FEMA task orders represents our consolidated revenues less the revenues generated from the FEMA task orders.

Ref (b): Operating income attributable to the remaining contract portfolio less the FEMA task orders represents the Company’s consolidated operating income, determined in accordance with GAAP, less the operating income derived from the FEMA task orders. Operating income for the FEMA task orders is derived by subtracting from the revenue attributable to such task orders during the three months ended March 31, 2022 of $39.8 million the following amounts attributable to the task orders: contract costs of $33.7 million and general & administrative costs of $0.6 million. Similarly, for the six months ended March 31, 2022 operating income for the FEMA task orders is derived by subtracting from the revenue attributable to the tasks orders of $130.9 million the following amounts attributable to the task orders: contract costs $117.9 million and general & administrative costs of $1.1 million. Operating income for the remaining contract portfolio for the three and six months ended March 31, 2022 represents the Company’s consolidated operating income for such period less the operating income attributable to the FEMA task orders for such period.

Ref (c): Net income attributable to the remaining contract portfolio less the FEMA task orders represents the Company’s consolidated net income, determined in accordance with GAAP, less the net income derived from the FEMA task orders. Net income for the FEMA task orders is derived by subtracting from the revenue attributable to such task orders during the three months ended March 31, 2022 of $39.8 million the following amounts attributable to the task orders: contract costs of $33.7 million, general & administrative costs of $0.6 million, and income tax expense of $1.4 million. Similarly, for the six months ended March 31, 2022 net income for the FEMA task orders is derived by subtracting from the revenue attributable to the tasks orders of $130.9 million the following amounts attributable to the task orders: contract costs $117.9 million, general & administrative costs of $1.1 million, and tax expense of $3.1 million. Net income for the remaining contract portfolio for the three and six months ended March 31, 2022 represents the Company’s consolidated net income for such period less the net income attributable to the FEMA task orders for such period.

Ref (d): Diluted earnings per share (diluted EPS) for the FEMA task orders is calculated using the net income attributable to such task orders as opposed to GAAP net income. Diluted EPS for the remaining contract portfolio (total contract portfolio excluding the FEMA task orders) is calculated by subtracting the diluted EPS for the FEMA task orders from the Company's total diluted EPS.

Ref (e): EBITDA attributable to the FEMA tasks orders of $5.5 million and $11.9 million for the three and six months ended March 31, 2022, respectively, is arrived at through the same calculation as operating income as there are not any depreciation and amortization costs attributable to the FEMA tasks orders. EBITDA for the remaining contract portfolio is calculated by subtracting the EBITDA attributable to the FEMA task orders from the Company’s total EBITDA.

DLH (NASDAQ:DLHC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more DLH Charts.
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more DLH Charts.